Manufacturing

H.S. Pordal (harbinder.pordal@stress.com) is principal of Stress Engineering Services, Inc., 7030 Stress Engineering Way, Mason, OH 45040; (513) 336-6741.

Clint A. Haynes is vice-president of Stress Engineering Services, Inc., 7030 Stress Engineering Way, Mason OH 45040, (513)336-6741.

Sachin Kurian is analyst with Stress Engineering Services, Inc., 7030 Stress Engineering Way, Mason OH 45040, (513)336-6741.

Articles

Model-based approaches and digital analytics are improving flexibility at both the equipment and the manufacturing-line level. 

Will Advanced Technology Redefine Bio/Pharma's Agility?

Allison Cacciatore, Facilities Design and Engineering, Pharmatech Associates

For drug sponsors that are considering building their own manufacturing facilities, an expert project team is crucial.

Best Practices for Designing and Building a Pharmaceutical Manufacturing Facility

Honeywell’s project team has remotely and efficiently migrated Richter Gedeon’s process control system with limited onsite staffing and resources.

Honeywell Completes Remote Control System Migration for Hungarian Pharma Manufacturer

AbCellera’s recent acquisition of the OrthoMab bispecific platform is expected to accelerate antibody product development.

AbCellera’s Acquisition of OrthoMab Bispecific Platform Propels Antibody Development

The companies have formed a collaboration to develop a novel human recombinant protein as a therapeutic candidate against COVID-19.


Airway Therapeutics, Celonic Group Partner on New COVID-19 Therapeutic

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.

Ensuring Smooth Tech Transfer of Bioprocesses to Outsourcing Partners

Alberto Santagostino is senior vice-president and head of cell and gene technologies at Lonza Pharma and Biotech. 

Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost. 

Using the ‘Cubic Effect’ to Drive Cell and Gene Therapy Commercialization

Susan Haigney is managing editor of Pharmaceutical Technologyand Pharmaceutical Technology Europe, susan.haigney@ubm.com.

Unforeseen challenges can be avoided in technology transfer by evaluating the variety of processes involved.

Evaluating the Tech Transfer Process

A groundbreaking ceremony was held in Rahway, NJ for Merck’s new FLEx facility that incorporates G-CON’s prefabricated cleanroom units.

Merck Holds Groundbreaking Ceremony for Formulation Laboratory and Experimental Center

Pharmaceutical Technology spoke with Roger Croucher, senior manager, R&D projects, at Catalent Pharma Solutions; Daniel M. Bowles, senior director, chemical development, at Cambrex; and Kurt J Kiewel, director, new product development and analytical services, also at Cambrex about best practices for a successful technology transfer. 

Technology Transfer